SL
IBB icon

Salomon & Ludwin’s iShares Biotechnology ETF IBB Stock Holding History

Salomon & Ludwin’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-71
Closed -$9.2K – 2155
2025
Q2 		$9.2K Hold
71
– – ﹤0.01% 494
2025
Q1 		$9.08K Hold
71
– – ﹤0.01% 460
2024
Q4 		$9.39K Sell
71
-539
-88% -$75.8K ﹤0.01% 452
2024
Q3 		$88.8K Hold
610
– – 0.01% 204
2024
Q2 		$83.7K Sell
610
-16
-3% -$2.14K 0.01% 211
2024
Q1 		$85.9K Hold
626
– – 0.01% 272
2023
Q4 		$76.6K Hold
626
– – 0.01% 256
2023
Q3 		$76.6K Buy
+626
New +$79.6K 0.01% 256
2019
Q1 		– Sell
-145
Closed -$14K – 250
2018
Q4 		$14K Buy
+145
New +$15.4K ﹤0.01% 135

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Salomon & Ludwin's IBB Position: Q3 2025 in Review

Salomon & Ludwin sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 71 shares — an estimated $9.2K sold.

Salomon & Ludwin first reported a position in IBB in Q4 2018 and held it in 9 quarters. The position peaked at $88.8K in Q3 2024. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Salomon & Ludwin reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Salomon & Ludwin sold 71 iShares Biotechnology ETF shares in Q3 2025, an estimated $9.2K.
  • Salomon & Ludwin first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 9 quarters.
  • Salomon & Ludwin's iShares Biotechnology ETF position peaked at $88.8K in Q3 2024.
  • 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Salomon & Ludwin's 13F filing for Q3 2025, filed 21 Oct 2025.